P53 EXPRESSION IN BREAST-CANCER RELATED TO PROGNOSTIC FACTORS

被引:0
|
作者
CIESIELSKI, D
DZIEWULSKABOKINIEC, A
ZOLTOWSKA, A
ROSZKIEWICZ, A
KOPACZ, A
WOJTACKI, J
机构
[1] MED UNIV GDANSK,DEPT RADIOTHERAPY,PL-80211 GDANSK,POLAND
[2] MED UNIV GDANSK,DEPT PATOMORPHOL & ONCOL SURG,PL-80211 GDANSK,POLAND
[3] PCK HOSP,DIV RADIOTHERAPY,GDYNIA,POLAND
关键词
BREAST CANCER; P53; PROTEIN; TUMOR SUPPRESSOR GENES; ESTROGEN AND PROGESTERONE RECEPTORS; PROGNOSTIC FACTORS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this article the results of molecular marker p53 examinations were presented in relation to the following established breast cancer prognostic factors: age, histologic type, histologic grade, lymph node involvement, tumor size as well as estrogen a progesterone receptor status. Twenty one percent of these primary breast cancer specimens exhibited the overexpression of p53 protein. Significant associations were found between p53 overexpression and younger age, high histologic grade and low content of estrogen and progesterone receptors. Identification of p53-positive breast carcinomas potentially represents a clinically useful indicator of breast cancer aggressiveness.
引用
收藏
页码:235 / 237
页数:3
相关论文
共 50 条
  • [41] HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
    Allini Mafra da Costa
    José Humberto Tavares Guerreiro Fregnani
    Paula Roberta Aguiar Pastrez
    Vânia Sammartino Mariano
    Estela Maria Silva
    Cristovam Scapulatempo Neto
    Denise Peixoto Guimarães
    Luisa Lina Villa
    Laura Sichero
    Kari Juhani Syrjanen
    Adhemar Longatto-Filho
    Infectious Agents and Cancer, 12
  • [42] Expression of p53 Protein in Premenopausal Women as Risk Factors for Breast Cancer
    Rashidah, S.
    Rashmizal, Hairil A. R.
    Ho, S. E.
    Mazlina, Wan M. S.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2016, 11 (02): : 189 - 198
  • [43] Environmental factors in relation to breast cancer characterized by p53 protein expression
    Furberg, H
    Millikan, RC
    Geradts, J
    Gammon, MD
    Dressler, LG
    Ambrosone, CB
    Newman, B
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (09) : 829 - 835
  • [44] SERUM P53 AUTOANTIBODIES - INCIDENCE IN FAMILIAL BREAST-CANCER
    GREEN, JA
    MUDENDA, B
    JENKINS, J
    LEINSTER, SJ
    TARUNINA, M
    GREEN, B
    ROBERTSON, L
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) : 580 - 584
  • [45] THE P53 TUMOR-SUPPRESSOR GENE IN BREAST-CANCER
    ELLEDGE, RM
    ALLRED, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 39 - 47
  • [46] INHERITED P53 GENE-MUTATIONS IN BREAST-CANCER
    SIDRANSKY, D
    TOKINO, T
    HELZLSOUER, K
    ZEHNBAUER, B
    RAUSCH, G
    SHELTON, B
    PRESTIGIACOMO, L
    VOGELSTEIN, B
    DAVIDSON, N
    CANCER RESEARCH, 1992, 52 (10) : 2984 - 2986
  • [47] MAINTENANCE OF P53 ALTERATIONS THROUGHOUT BREAST-CANCER PROGRESSION
    DAVIDOFF, AM
    KERNS, BJM
    IGLEHART, JD
    MARKS, JR
    CANCER RESEARCH, 1991, 51 (10) : 2605 - 2610
  • [48] OVEREXPRESSION OF P53 IN NODE-POSITIVE BREAST-CANCER
    ALLRED, DC
    CLARK, GM
    FUQUA, SAW
    ELLEDGE, RM
    OSBORNE, CK
    LABORATORY INVESTIGATION, 1994, 70 (01) : A12 - A12
  • [49] C-ERBB-2 ONCOGENE RELATED TO P53 EXPRESSION, CELL-PROLIFERATION AND PROGNOSIS IN BREAST-CANCER
    JI, H
    LIPPONEN, P
    AALTOMAA, S
    SYRJANEN, S
    SYRJANEN, K
    ANTICANCER RESEARCH, 1993, 13 (04) : 1147 - 1152
  • [50] Prognostic value of cytosolic p53 protein in breast cancer
    Montero, S
    Guzmán, C
    Vargas, C
    Ballestín, C
    Cortés-Funes, H
    Colomer, R
    TUMOR BIOLOGY, 2001, 22 (05) : 337 - 344